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Frequent incidents of antibiotic-resistant biofilm forming pathogens in community-
associated and hospital-acquired infections have become a global concern owing to
failure of conventional therapies. Nano-antibiotics (NABs) are de novo tools to overcome
the multi-drug resistant mechanisms employed by the superbugs. Inhibition of biofilm
formation is one of those strategies to curb multi drug resistance phenomenon. In the
current study, the anti-biofilm and antibacterial potential of newly synthesized cefotaxime
loaded chitosan based NABs have been investigated. Both bare and cefotaxime loaded
NABs were prepared by ionotropic gelation method. They were found carrying positive
zeta potential of more than +50 mV, indicating highly stable nano-dispersion. Moreover,
microscopic studies revealed their size as less than 100 nm. NABs were tested against
clinical isolates of multi drug resistant Klebsiella pneumoniae, Pseudomonas aeruginosa,
Escherichia coli, and methicillin resistant Staphylococcus aureus and wherein they
demonstrated broad-spectrum anti-biofilm and anti-pathogenic activity. Thus, in vitro
synergistic action of cephalosporin drugs and chitosan polymer at nano-scale in
contrast to free antibiotics can be an improved broad-spectrum strategy to thwart
resistance mechanisms in both Gram-positive and Gram-negative resistant pathogens.
Keywords: biofilm, chitosan nano-carriers, cephalosporins, drug resistance, growth kinetics, zeta potential
INTRODUCTION
Though, it is a mutually agreeable fact that bacteria has no definite nervous system but it is also
conceded that they evolve certain survival mechanisms that allow them to exist in any environment.
Biofilm formation is one of such survival mechanisms. Most of the bacterial species prefer to
live in a well-developed community (biofilm) rather than planktonic form (isolated individual
cells; Dheilly et al., 2010; Sayem et al., 2011). Along with numerous other benefits, biofilms also
provide the basic mechanism of resistance to antibiotics, antibodies, bacteriophages, disinfectants
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and other host defense systems (Dheilly et al., 2010) by
constituting a multi-layered protection mechanisms (Stewart,
2002). Extracellular polymeric substance (EPS) covering the
biofilms make them impermeable to many antibiotics. Likewise,
in biofilms microbes exhibit slow growth rate which further
makes them resistant to therapeutic agents. Furthermore, biofilm
forming microbes develop adaptive stress responses which
collectively evince another defense mechanism. The formation
of persister cells are further addition to this menace and is the
main cause of recurrent and chronic infections (Lewis, 2005).
Biofilms also facilitate the horizontal or lateral gene transfer
(Madsen et al., 2012) which is considered a significant feature
in the evolutionary process of acquiring antibiotic resistance
genes between species. Biofilms also provide a wide variety of
genetic elements (plasmids) to be transferred among unrelated
bacterial species including genes that promote biofilm formation
and responsibles for resistance (Donlan, 2002).
Extracellular DNA (eDNA) which is formed by the autolysis
of a microbial subpopulation also makes an integral part of
microbial biofilms and plays a foremost role in the stability
of the biofilms (Watnick and Kolter, 2000). These biofilms
accumulate large quantity of antibiotic degrading enzymes too
(Delcour, 2009). In addition, biofilm formation is associated
with the virulence of pathogenic bacteria, and cells included
within a biofilm are generally 1000 times more resistant. National
Institutes of Health (NIH) has estimated that 70% of all microbial
infections in the world are associated with biofilms (Perumal and
Mahmud, 2013). It is, therefore, a major concern not only in
health care systems but in certain other domains as well. It has
also been a major source of contamination in the food industry,
water supply pipes, medical implants, catheters and equipment
etc (Dheilly et al., 2010; Perumal and Mahmud, 2013).
The effectiveness of many antimicrobial agents is currently
decreasing owing to increasing prevalence of multidrug-resistant
(MDR) pathogens (Fabbretti et al., 2011). The emergence of
these MDR pathogens remains a serious challenge to medicine
and healthcare systems (Carlet et al., 2012). One of the
mechanisms for such resistance is the formation of biofilms.
If antibiotics cannot traverse the biofilm they fail to eradicate
other defense strategies. Therefore, it is important to search
for alternative therapeutics to control biofilm-associated MDR
infections (Perumal and Mahmud, 2013; Kirker et al., 2015).
The development of anti-biofilm and anti-MDR strategies
is therefore a major area of interest and currently constitutes
an important field of investigation. Albeit, various naturally
occurring compounds (including plant extracts) have been
investigated in this regard (Salta et al., 2013). However, nano-
antimicrobials (NAMs) are offering more promising future to
beat MDR phenomenon (Allaker and Memarzadeh, 2014; Jamil
et al., 2015). NAMs can also overcome resistance caused by
biofilm formation and can prevent biofilm’s further growth as
well (Jamil et al., 2015). Recently, various NAMs have displayed
their anti-biofilm potential to combat resistance mechanisms.
Liposomes help thrashing biofilms by promoting adsorption at
the outer surfaces of biofilms (Smith, 2005). Besides, silica nano-
particles (NPs) act by releasing large amount of Nitric oxide (NO;
Hetrick et al., 2009). Analogously, ZnO, TiO2, MgF2 NPs and
super paramagnetic iron oxide NPs (SPIONs) have also inhibited
biofilm formation (Pelgrift and Friedman, 2013). The rationale
behind successful eradication of biofilms lies in strong interaction
between biofilms and NAMs. The majority of NAMs bear positive
charge that attaches firmly to biofilm matrixes carrying negative
charge (Hajipour et al., 2012). However, due to metallic NPs
associated toxicity issues, nano-medicine research focus has been
shifted toward bio-based NPs or nano-carrier systems (NCS).
In general, NCS protects the drug from both endogenous and
exogenous factors and provide a sustained release and more
enhanced bioactivity.
Cefotaxime is a third generation broad spectrum cephalos-
porins for parenteral administration with a short half-life
of 0.8–1.4 h, it is bactericidal and mainly used in the
treatment of infections caused by Gram-positive and Gram-
negative microorganisms. Very recent and frequent emergence
of extended spectrum beta lactamases (ESBL) and metallo
beta lactamases (MBL) are reducing the susceptibility of
all cephalosporins including cefotaxime. Therefore, present
investigation has been carried out in an attempt to enhance the
bactericidal activity of this β-lactam antibiotic synergistically with
antimicrobial bio polymer chitosan to render it more effective
against biofilm producing MDR pathogens.
MATERIALS AND METHODS
Chitosan-medium molecular weight was purchased from Sigma–
Aldrich (Product number 448877, 75–85% deacetylation, 200–
800 cP viscosity of 1% w/v in 1% v/v acetic acid). Pentasodium
triphosphate (TPP) and glacial acetic acid were also procured
from Sigma–Aldrich. All antibiotic disks were obtained from
Oxoid. Nutrient agar and nutrient broth were purchased from
Oxoid. Cefotaxime sodium for injection (0.5 g) was procured
from Sanoffi Aventis Pakistan Limited. Standard stock solution
of cefotaxime sodium was prepared by dissolving 1 mg/mL in
sterilized water.
Culture Collection
The clinical isolates were obtained from Al-Sayed Hospital
(Pvt) Ltd, Rawalpindi and stored at −80◦C in nutrient broth
containing 20% glycerol. Their identities were confirmed by
biochemical test using API (analytical profile index) kits.
For the purpose of this study, we had collected pathogenic
bacteria which were capable of biofilm formation and were
documented as causative agents for severe infections. Clinically
resistant pathogens used in this study includes Klebsiella
pneumoniae (KP), Pseudomonas aeruginosa, Escherichia coli
(E. coli), and Methicillin resistant Staphylococcus aureus (MRSA).
We could not get clinical isolates of Listeria monocytogenes, so
L. monocytogenes ATCC 13932 had been employed for this study.
Inoculum was prepared by the method described in literature
with slight modifications. All the bacterial strains were recovered
on a fresh nutrient agar (Oxoid) plate 24 h prior to antimicrobial
test. To prepare the inoculum, colonies from fresh agar were
transferred into sterile Mueller Hinton (MH) liquid growth
medium and incubated at 37◦C overnight. The optical density
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was adjusted to 0.1 at 600 nm wavelength (Perumal and Mahmud,
2013).
Resistance Spectra by Disk Diffusion
Method
Selected microbes were subjected to antibiotic disks by standard
Kirby Bauer method and their resistance patterns were
studied and compared to CLSI guidelines. Following antibiotic
disks were used including Ceftazidime (CAZ), Cefotaxime
(CTX), Imipenem (IPM), Cefepime (FEP), Ceftriaxone (CRO),
Aztreonam (ATM), Ampicillin (AMP), Vancomycin (VA),
Augmentin (AMC), Colistin (CT), Cefoxitin (FOX), and
Minocycline (MH). All selected bacterial cultures were marked
as resistant or susceptible based upon their zones of inhibition.
Quantification of Antibiotics by
Nanophotometer
UV-Vis spectrophotometer (Nanophotometer Implen) was used
for this purpose (El-Shaboury et al., 2007; Bushra et al., 2014).
Volumetric dilutions of cefotaxime were prepared in triplicate
from stock solution. λmax was obtained after the wave scan
for 200–900 nm range. Calibration curve was constructed with
the average absorbance of three replicates. The trend line was
obtained by linear regression with standard equation and R
squared value.
Chitosan Nanoparticles (CSNPs)
Fabrication
Ionotropic gelation method was used to fabricate Chitosan
Nanoparticles (CSNPs; Du et al., 2009; Jamil et al., 2016).
Ionotropic gelation is based on the ability of poly electrolytes to
cross link in the presence of counter-ions to form hydrogel beads
also called as gelispheres (Patil et al., 2012). These gelispheres
have the ability to control the release of drug. Cefotaxime
solution was prepared in tripolyphosphate (TPP) and it was
then added dropwise in chitosan (CS) solution with constant
stirring. The TPP diffuses slowly into the CS solution forming
a three dimensional lattice of ionically crosslinked moiety that
has entrapped drug in it (Patil et al., 2012). It was then subjected
to sonication for another 30 min by using Sonozap ultrasonic
homogenizer 25 kHz. These NPs were then centrifuged at 12000 g
for 10 min.
Nanoparticles Characterizations
The detection and characterization of nanoparticles entail
particular challenges. As particle size is a key criterion in
nanotechnology, maintaining particle size both in vitro and
in vivo is crucial. Stability of NPs is determined mainly by
their size maintenance. Flocculation and aggregation due to van
der Waals forces should be avoided as the behavior of NPs is
remarkably different from the bulk material of the same matter.
Bulk material does not change its physical properties as the size of
matter changes, while the NCS display size dependent properties.
As a general rule, extent of size reduction is directly proportional
to the surface area. Increased surface area contributes toward
greater activity.
Scanning Electron Microscopy (SEM)
Scanning electron microscopy uses electrons instead of light to
form an image and is one of the most widely used techniques for
the characterization of nanostructures. Jeol JSM 6490A analytical
scanning electron microscope was used for this purpose. Sample
was prepared by placing a small drop of formulation on glass
slide. Gold coating by Jeol Quick Auto Coater (JFC-1500) ion
sputtering device was done for 6 s only. Analyses of both empty
and drug loaded nanoparticles were carried out at the resolution
of 20 kV and 3000–50000× magnification by the procedure
already published (Jamil et al., 2016).
Atomic Force Microscopy (AFM)
SEM gives a 2D image while AFM can provide a 3D topographic
picture of prepared nano-systems. Agilent Pico Plus was used
for this purpose. The AFM probe has a very sharp tip, often less
than 100 Å diameter, at the end of a small cantilever beam. The
probe is attached to a piezoelectric scanner tube. Inter-atomic
forces between the probe tip and the sample surface cause the
cantilever to deflect as the sample’s surface topography or other
properties change. A laser light reflected from the back of the
cantilever measures the deflection of the cantilever. Based on the
type of application, different operation modes of AFM are used
like the contact mode, semi contact mode and tapping mode
(Suresh, 2015). However, for this study, all the images were taken
in tapping mode at ambient conditions.
Fourier Transform Infrared Spectroscopy
(FTIR) Spectra
Fourier Transform Infrared Spectroscopy was done for
qualitative analysis of prepared formulations. Infrared
spectroscopy is associated with vibrational energy of atoms
or group of atoms in a material. It gives peaks for each functional
groups and also gives a clue about bonding and interactions.
Perkin Elmer FTIR spectroscope was used to analyze dry sample
after preparing their pallet with KBr (FTIR grade Merck) while
liquids were analyzed directly. The spectral resolution was
4 cm−1, with 96 scans, and an aperture of 4 mm. The optimum
beam incidence angle was 45◦ and all the spectra were acquired
in a range between 4000 and 600 cm−1.
Determination of Zeta Potential
Zeta potential was measured to get an indication about long
term stability of nano-formulations. Zetasizer Nano ZS (Malvern
Instruments, UK) using Doppler electrophoresis as the basic
principle of operation was used in this study. The data collected
were then imported to Excel and the means and standard
deviations of the replicate measurements were calculated.
Determination of Encapsulation
Efficiency
The encapsulation efficiency (EE) of nanoparticles was calculated
by the method earlier mentioned (Rotar et al., 2014). Drug
loaded CSNPs were isolated from the free drug by centrifugation
(12,000 g for 15 min, Eppendorf 5415D, Germany). Free drug
in the supernatant was quantified by spectrophotometer at λmax
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(298) obtained from wave scan. The concentration of drug in
the supernatant was estimated by the equation obtained from
standard curve. Experiments were performed in triplicate and the
EE was calculated as follows:
EE = (total drug− un encapsulated drug)÷ total drug× 100
Antimicrobial Potential of the Prepared
Nano-antibiotics (NABs)
Antibacterial activity of blank and β-lactam antibiotic loaded
CSNPs were evaluated according to standard liquid micro-
dilution susceptibility assays. To this aim, selected microbes were
grown in nutrient broth until the exponential growth phase at
37◦C while shaking. Bacterial turbidity was compared to Mc-
Farland solution. Ten microliters of the bacterial suspension were
added to 9 mL broth and similar concentration of antibiotic and
drug loaded CSNP were added in inoculated broth. Test tubes
were incubated in shaker incubator at 37◦C overnight. Optical
densities values were taken after every 24 h for 144 h at 595 nm
on Elisa Multi-plate reader (Jamil et al., 2016). Both positive
and negative controls were added in this assay. Negative control
contains only the nutrient broth without culture and served as
control of any possible contamination while the positive control
contains nutrient broth and inoculum to serve as a control of
cell-viability.
At the end of experiment colony forming unit (CFU) assay was
done to confirm the results. Serially diluted bacterial suspensions
were plated on Nutrient agar surface and incubated for 48 h at
37◦C. Results were expressed as log10 CFU/ml.
Anti-Biofilm Potential of the Prepared
Nano-antibiotics
To assess the anti-biofilm activity of cephalosporin loaded CSNPs
against clinically important pathogens; MicroTiter Plate (MTP)
assay was carried out using 96-well flat bottom polystyrene titer
plates (Kirker et al., 2015).
Biofilms were formed on ELISA plate by the method of
George with few modifications (George, 2011). Briefly, all selected
pathogens were cultured on fresh Petri plate from stocks
preserved at −80◦C and from that pure media inoculum was
prepared. Turbidity was compared to that of McFarland turbidity
standard and 10 µL inoculum was added in test tube containing
9 mL of freshly sterilized nutrient broth. Nano-antibiotic and
simple antibiotic solution prepared at same concentration were
then added in each test tube. Approximately 200 µL of each
sample was added in each well of 96 well ELISA dish. Each
sample was prepared in triplicate and incubated at 37◦C. After
incubation, planktonic cells were removed by turning the plate
upside down. It was then submerge gently in a small tub of water
and water was removed. Washing was done thrice to remove
all the unattached cells and also to lower background staining.
Afterwards 200 µL of a 0.1% solution of crystal violet was added
to each well of the microtiter plate. It was left in incubator for 10–
15 min. Crystal violet solution was removed by tilting the plate
and by rinsing with water 3–4 times. It was then blot dried.
To quantify the biofilms, 200 µL of 30% v/v acetic acid
solution was added to each well to completely solubilize
the crystal violet. The microtiter plate was incubated at
room temperature for 10-15 min. The resultant solution was
transferred to a new microtiter dish and absorbance reading was
taken in a micro-plate reader at 595 nm (George, 2011; Perumal
and Mahmud, 2013).
RESULTS
Resistance Spectra by Disk Diffusion
Method
Resistance spectra of selected microbes were determined by
standard disk diffusion method. Results were compared to
CLSI guidelines to categorize organisms either as susceptible
or resistant. Cefoxitin was used as an indicator of methicillin
susceptibility disks and an inhibition zone diameter of ≤14 mm
was reported as methicillin resistant. According to our results,
S. aureus was resistant to cefoxitin (FOX) that is why we marked
it as Methicillin Resistant S. aureus (Figure 1). It was also
resistant to whole range of tested cephalosporins (Table 1).
Likewise, K. pneumoniae was also resistant to all cephalosporins
and augmentin as well, but was susceptible to Imipenem (IPM),
Colistin (CT) and Minocycline (MH). E. coli was found to be
ESBL positive as the inhibition zone expansion was observed
with Augmentin (Figure 1C). In case of P. aeruginosa, it was
susceptible to Colistin (CT) only otherwise it was observed
to be highly resistant to all other tested antibiotics. So all
the clinical pathogens were found to be highly resistant to
the available therapeutic options. However, L. monocytogenes
(ATCC 13932) was susceptible to all tested antibiotic disks except
vancomycin.
Characterization of Nano-Particles
Ultramicroscopic characterization of nanoparticles was done to
gather a firsthand information on particles morphology, size and
distribution. AFM was performed to get surface topography and
size distribution images of nano-formulations. 3D AFM images
of both nano-systems revealed that both nano-formulations were
homogeneously dispersed and a maximum height of 50 nm was
observed for empty CSNPs and 51 nm for cefotaxime loaded
CSNPs (Figure 2). Both empty and loaded nano-formulations
were found to be quite uniform. However, cefotaxime loaded
CSNPs were displaying more dense population. SEM results
revealed that empty and cefotaxime loaded NPs were in the
size range of less than 100 nm. Both AFM and SEM analysis
demonstrated that there was more concentrated and more
dense population of drug loaded NPs as compare to blank NPs
(Figure 3).
FTIR Spectra
Fourier Transform Infrared Spectroscopy analysis of chitosan
raw material, cefotaxime powder empty CSNPs and drug loaded
CSNPs are shown in Figure 4. FTIR spectra of CS raw material
revealed major peaks at 3401, 2878, 1651, 1380, 1080, and
at 607 cm−1 that corresponded to O-H stretching peak, C-H
stretching, N-H stretch, CH2 bending, C-O-C stretch and
-C≡ C-H, respectively (Figure 4A).
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FIGURE 1 | Zones of Inhibitions formed on nutrient agar surface by different antibiotic disks against (A) Methicillin-resistant Staphylococcus aureus
(MRSA), (B) Klebsiella pneumoniae (C) Escherichia coli displaying extended spectrum beta lactamases (ESBL) phenomenon exhibited by extension
in zone of inhibition formed between augmentin and cephalosporins (D) Pseudomonas aeruginosa and (E) Listeria monocytogenes, after incubation
at 37◦C after 24 h.
In case of CSNPs more broad, strong and characteristic peak
for CS was observed at 3406 cm−1 representing 0-H stretching
or H-bonding for alcohol or phenols instead of 3401 cm−1
(for CS) indicating that H bonding is enhanced during NPs
formation while the amide peak shifted from 1651 to 1644 cm−1.
A new sorption bands at 2089 cm−1 appear, which shows that
the ammonium groups are crosslinked with tripolyphosphate
molecules.
Analysis of FTIR spectra of CSNPs showed that it was very
similar to that of cefotaxime loaded CSNPs (Figures 4C,D). This
fact was predictable because the amount of drug loaded in nano-
scaffold was very small as compare to the amount of building
blocks of nano-structures, that is why no peaks of cefotaxime was
observed in the drug loaded nanoparticles.
Determination of Zeta Potential
According to our results, both the blank CSNPs and drug
loaded CSNPs had demonstrated a zeta potential of more than
+50 mV (Figures 5A,B). This can be predicted from the
data that β-lactam loaded nano-sytems are offering long term
stability.
Determination of Encapsulation
Efficiency
Encapsulation efficiency was determined at different drug
concentrations. It was observed that EE augmented with increase
in concentration of drug. It was calculated to be 60% at
100 µg/mL; 71% at 800 µg/mL and 90% at 2000 µg/mL
concentration.
Antimicrobial Potential of the Prepared
Nano-antibiotics
Drug loaded CSNPs were prepared with 1000 µg/mL of drug
concentration and tested against above-mentioned pathogens by
broth dilution assay (Figure 6). It was compared to both plain
antibiotic solution and bare CSNPs for 7 days (144 h). It was
observed that nano-cefotaxime was highly effective against all
MDR pathogens while the simple antibiotic could not control
them at all. However, when we compare efficiency of drug
loaded CSNPs to bare CSNPs, the difference seems to be low.
In case of P. aeruginosa the activity was equal. However, for
other pathogens bare nano-systems were effective till first 48 h.
TABLE 1 | Zones of Inhibition formed by clinical isolates against different tested antibiotic disks.
Pathogens AMC CRO FOX FEP CAZ CTX ATM CT IPM AMP VA MH
Zones of inhibition (mm)
MRSA 18 – – – – – – – 17 15 20 20
Klebsiella pneumoniae – – – – – – – 15 23 – – 15
Escherichia coli – – 24∗ 16∗ 19∗ – 15 14 28 – – 18
Pseudomonas aeruginosa – – – – – – – 16 12 – – –
Listeria monocytogenes (ATCC 13932) 30 29 26 29 29 30 33 15 30 25 – 16
Where Augmentin (AMC), Ceftriaxone (CRO), Cefoxitin (FOX) Cefepime (FEP), Ceftazidime (CAZ), Cefotaxime (CTX), Aztreonam (ATM), Colistin (CT), Imipenem (IPM),
Ampicillin (AMP), Vancomycin (VA), and Minocycline (MH). ESBL phenomenon exhibited by increase in zone of inhibition. Whereas (–) means ‘no zone of inhibition.
∗ indicates ESBL phenomenon marked by increase in zone of inhibition caused by AMC and cephalosporin discs.
Frontiers in Microbiology | www.frontiersin.org 5 March 2016 | Volume 7 | Article 330
fmicb-07-00330 March 18, 2016 Time: 11:40 # 6
Jamil et al. Nano-antibiotics to Combat MDR Biofilms
FIGURE 2 | Atomic force microscopic images of surface topography and 3-Dimensional (3D) structures of empty CSNPs (A,B) and cefotaxime loaded
CSNPs (C,D) respectively. A small drop of sample was dried on glass slide and all images were taken at room temperature without any sample treatment. Results
obtained depict height of 50 and 51 nm.
Nonetheless, the drug loaded CSNPs were proved to be more
effective in contending the other four pathogens including ATCC
L. monocytogenes for more prolonged period of time. At the end
of experiment CFU count was done to confirm the hypothesis
(Figure 7). It also endorse the above statement as no colonies
were observed in case of P. aeruginosa, however, in other
pathogens growth was observed only in case of CSNPs.
Anti-Biofilm Activity of the Fabricated
Nano-antibiotics
It was observed from the present study that the formation and
intensity of biofilm increase with the intensity of pathogenicity
and resistance spectrum of pathogens. The most resistant Gram-
negative pathogens were K. pneumoniae and P. aeruginosa and
they formed more intense biofilms. Whereas, L. monocytogenes
(ATCC) was most susceptible to antibiotic disks and was the
weakest in term of biofilm intensity. Antibiotic alone fails to
eradicate the biofilm, however, nano-cefotaxime was found to
be highly effective in controlling the formation of biofilms
(Figure 8). CSNPs were also found to be efficient in controlling
the biofilms but the drug loaded CSNPs were more effective in
every case. It may be concluded that bare CSNPs can effectively
kill the planktonic cells, however, cannot efficiently control
biofilm formation. Whereas drug loaded CSNPs were more
FIGURE 3 | Scanning electron microscopy (SEM) of bare (A) and drug loaded CSNPs (B). SEM images were taken by placing a tiny droplet of sample on
l × l cm glass slide and it was spreaded evenly. After gold sputtering, images were taken at ambient conditions. SEM images depicted spherical particles having
diameter of less than 100 nm.
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FIGURE 4 | Fourier Transform Infrared Spectroscopy spectra (A) Chitosan raw material (B) Cefotaxime raw material (C) bare CSNPs (D) cefotaxime
loaded CSNPs. FTIR spectrum of powders were taken after mixing raw material with KBr. Whereas liquid samples were analyzed directly by palcing a tiny drop over
glass assembly. FTIR spectra indicated no new bond formation so the drug is not reacting chemically with nano-scaffolds.
effective as a therapeutic agent to prevent the formation of biofilm
and also in terms of killing pathogens for prolonged period of
time.
DISCUSSION
Biofilms are defined as microbial communities of cells that
are irreversibly attached to a substratum or to an interface
or to each other, and are embedded into a matrix of EPSs
that they have produced. There are as many different types
of biofilms as are bacteria, and that a single bacterium may
even make several different types of biofilms under different
environmental conditions (Karatan and Watnick, 2009). These
biofilms are offering inherent barrier to the penetration of
conventional antibiotics. Though anti-biofilm potential of plant
extracts was reported by many others (Perumal and Mahmud,
2013), yet this study has been designed to sort out the potential
of antibiotic loaded chitosan NPs as an antibacterial and anti-
biofilm agents. Cefotaxime has been used for this purpose. Albeit,
numerous methods are available for qualitative and quantitative
assays of antibiotics, nevertheless the UV-Vis Spectrophotometric
method has proved to be simple, effective, fast, economical
and reproducible for quantification of cefotaxime sodium in
pharmaceutical form powder for injectable solution. Resultantly,
λmax was obtained at 298 nm. Similar method was also employed
by other authors though different λmax values were achieved by
them. According to Bushra et al. (2014) λmax value for cefotaxime
was obtained at 260 nm, at 228 nm (El-Shaboury et al., 2007),
and 253 nm (Hammood et al., 2011). NPs were formulated
by ionic gelation method that has proved to be most efficient
FIGURE 5 | Zeta potential. Measured by Malvern Zeta sizer at ambient conditions (A) empty CSNPs (B) β-lactam drug loaded CSNPs. Both empty and drug
loaded CSNPs are displaying zeta potential values greater than 50 mV. It indicates highly stable colloidal dispersion.
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FIGURE 6 | Comparative Anti-pathogenic ability of Aqueous solution of Antibiotic and Antibiotic loaded CSNPs against pathogens (A)
Methicillin-resistant Staphylococcus aureus (MRSA), (B) Escherichia coli (E. coli) (C), Klebsiella pneumoniae (KP), (D) Pseudomonas aeruginosa
(Pseudo) and (E) Listeria monocytogenes (Listeria). Pathogens were exposed to Antibiotic solution (AB), blank chitosan nano-particles (CSNPs), and antibiotic
loaded CSNPs (NAB). All samples were incubated at 37◦C for 144 h and after every 24 h reading were taken on ELISA plate reader at 595 nm. Negative control
contains only the media and no inoculum where as positive control contain inoculated media.
and convenient method. Engineered and naturally forming NPs
can vary widely in their physicochemical characteristics such as
shape, size, and charge. These characteristics have been reported
to impact their interactions with biofilm-coated surfaces (Ikuma
et al., 2015). Microscopic attributes were studied via AFM and
SEM wherein the results displayed much smaller size of NPs as
compared to previous studies. Previous studies have reported the
size of CSNPs in the range of 140–250 nm (Gan et al., 2005;
Nesalin and Smith, 2013; Chaubey and Mishra, 2014; Miladi et al.,
2015) while in this research size less than 100 nm was achieved.
Fourier Transform Infrared Spectroscopy spectroscopic
studies were carried out in order to confirm the formation of
NPs and type of interactions between antibiotic and polymer.
FTIR has proved to be a powerful and useful characterization
FIGURE 7 | Colony forming unit (CFU) assay. CFU assay was performed to count the viable bacteria after reaction of CSNPs and drug loaded CSNPs with
pathogens. CFU was done by plating 10µL of sample from each test tube after serial dilutions in normal saline (0.9% NaCl). All plates were then incubated for 48 h
and colonies were counted manually. CSNP, Chitosan nano-particles, NAB, Nano-antibiotic; KP, Klebsiella pneumoniae; Pseudo, Pseudomonas aeruginosa and
MRSA for Methicillin-resistant S. aureus.
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FIGURE 8 | Anti-biofilm activity of antibiotic suspension (AB) Chitosan nano-particles (CSNPs) and Cefotaxime loaded CSNPs (NAB) against
pathogens. Methicillin-resistant S. aureus (MRSA), Klebsiella pneumoniae (KP), Escherichia coli (E. coli), Pseudomonas aeruginosa (Pseudo), and Listeria
monocytogenes (Listeria) were incubated on ELISA plates at 37◦C for 24 h. Biofilms were stained by crystal violet stain and removed by 30% acetic acid solution.
This solution was then measured on ELISA plate reader at 595 nm.
method for polymers, and materials in general. This is quite an
economical, short time characterization that allows to establish
the chemical composition, microstructure, chemical interactions
and follow variation of specific functional groups with the
passage of time during reactions (Barrios et al., 2012).
Fourier Transform Infrared Spectroscopy spectrum of
chitosan showed resemblance with an already reported spectra
for this biopolymer (Khan et al., 2002; Qi et al., 2004; Vitali
et al., 2006). Spectrum of cefotaxime raw material was also
in accordance with previously reported spectrum for this
cephalosporin drug (Hammood et al., 2011). Likewise, FTIR
spectrum of empty CSNPs was similar to already reported
spectra, however, it was quite different from the spectrum of bulk
material that indicated the formation of NPs (Hosseini et al.,
2013; de Pinho Neves et al., 2014; Antoniou et al., 2015). The
spectrum for drug loaded NPs was almost superimposable to that
of empty nano-formlation indicating that there was no chemical
bonding between the drug and polymers (Figures 4C and 3B).
Zeta potential is an indicator of long term stability of
colloidal dispersions. Nanoparticles with a zeta potential between
−10 and +10 mV are considered approximately neutral, while
nanoparticles with zeta potentials of greater than +30 mV or
less than −30 mV are considered strongly cationic and strongly
anionic, respectively (Clogston and Patri, 2011) and represent
a stable formulation as there would be less aggregation and
flocculation as the repulsive forces become more strong (Gazori
et al., 2009). According to results, both the blank CSNPs and drug
loaded CSNPs were displaying highly positive zeta potential of
more than +50 mV (Figures 5A,B). This can be predicted from
the data that β-lactam loaded nano-systems are offering long term
stability. Positive zeta potential in the range of 21–45 was already
reported by many authors (De Campos et al., 2001; Miladi et al.,
2015; Zhang et al., 2016).
Encapsulation efficiency was determined at various
concentrations of cefotaxime to check the influence of drug
concentration on EE. It was observed that EE augmented
with increase in concentration of drug. However, the findings
indicated that if the drug was dissolved in CS solution and
TPP was added afterward it had resulted in very low EE (<3%).
Honary et al. (2014) encapsulated vancomycin in CSNPs and
reported 60–69% EE (Honary et al., 2014) while 42–55%
after encapsulation of 5-Fluorouracil. The well –characterized
CSNPs were further investigated for their antipathogenic and
anti-biofilm potential.
Bacterial biofilms were first described in 1943. Biofilm
formation is an intricate process and colloquially the biofilms
are also referred to as microbial cities. Preliminary step to
this phenomenon is the attachment to any solid surface
termed as ‘adsorption.’ These biofilms are sheltered by a self-
secretory matrix called EPS. This EPS hold the cells organized
and safeguard them against extraneous agents because of its
composition. Biofilms also aid in quorum sensing thus facilitating
microbes to communicate with each other. The composition
of EPS is protein, polysaccharides and extracellular DNA.
Biofilms can ensure maximum intake of nutrients from outside
environment. The organization of microbes in these biofilms is
such that ancient and dead cell recline in the center where the
metabolites get accumulated while the fresh and new cells lie
near the outer surface where the flow of materials is maximum.
These biofilms are offering an innate resistance mechanism to
conventional antibiotics, however, NAMs can encounter biofilms
successfully.
The interactions between NPs and the biofilm can be viewed
as a three-step process: (1) transport of NPs to the vicinity of the
biofilm; (2) attachment to the biofilm surface; and (3) migration
within the biofilms (Ikuma et al., 2015).
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It has been observed from the present study that the nano-
cefotaxime was highly effective in controlling the formation
of biofilms (Figure 8). Though anti-biofilm potential of plant
extracts has been reported by many others (Perumal and
Mahmud, 2013), however, this is the first report to prove the
anti-biofilm activity of cefotaxime loaded CSNPs. It has been
mentioned earlier that more than 70% pathogenic microbes are
biofilm forming and that is the main mechanism of resistance
in pathogens. Blank CSNPs also exhibited good potential in
lowering the biofilm formation intensity but fails to eradicate
it completely. Therefore it can be concluded that chitosan NPs
causes the clumping of bacterial mass and help to slow the growth
of pathogens, however, cannot control the biofilm formation
efficiently. Less intensity of biofilm is the direct result of less
number of pathogens in culture media. The drug loaded CSNPs
totally eradicated the pathogens and therefore biofilm formation.
CONCLUSION
Foregoing in view, it can be positively concluded that the main
mechanism of action by which NAMs control MDR pathogens
is inhibition of biofilm formation. The results in this research
have confirmed that chitosan can be a potential carrier system
for cefotaxime to target Gram-negative and Gram-positive multi
drug resistant microorganisms that have the tendency to form
microbial biofilms. The prepared NPs have been perceived to be
stable as carrying positive zeta of more than +50 mV and were
displaying homogeneity in both size and shape.
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